Effects of Occlusal Splint vs Occlusal Splint Added to Manual Therapy in Patients With Temporomandibular Disorders (MTvsOS)

April 30, 2025 updated by: Alfonso Javier Ibáñez-Vera, University of Jaén

Effectiveness of Manual Therapy Added to Splint Therapy Compared to Splint Therapy Alone in the Treatment of Temporomandibular Disorders in Patients Intended for Orthodontic Treatment: a Randomized Clinical Trial

A randomized clinical trial evaluates physiotherapy plus splint treatment versus conventional splint treatment in patients with myofascial-origin temporomandibular disorder (TMD). The study follows the ethical principles of the Declaration of Helsinki and has been approved by the Research Ethics Committee of the University of Jaén.

Methodology Participants, recruited from three dental clinics in Spain, must be adults diagnosed with TMD according to the Diagnostic Criteria for Temporomandibular Disorder (DC/TMD). Patients with health conditions that could hinder participation are excluded. They are randomly assigned to two groups: one receiving physiotherapy plus a splint, and the other receiving only a splint.

The sample size was calculated using G*Power, determining that at least 38 patients (19 per group) are required.

Assessments and Measurements Sociodemographic variables include age, sex, BMI, education level, and lifestyle habits. Various instruments are used to assess TMD and pain, such as the DC/TMD, the Fonseca Anamnestic Index, the Numerical Pain Rating Scale, and the Neck Disability Index.

Intervention Physiotherapy + splint group: Four 20-minute manual therapy sessions, including techniques for the temporomandibular joint and cervical muscles.

Splint-only group: Only splint use as prescribed by the dentist. Assessments are conducted before and after treatment for the physiotherapy group and at two time points for the splint-only group (before splint placement and one month later).

Data Analysis SPSS and MedCalc software will be used, with a 95% confidence level. Relationships will be analyzed through regression and Pearson correlation, and group comparisons will be performed using repeated measures ANOVA, Student's t-test, and Chi-square test. Effect size will be calculated using Cohen's d.

In conclusion, the study aims to determine the effectiveness of combined physiotherapy and splint treatment compared to splint-only treatment in patients with myofascial TMD.

Study Overview

Status

Completed

Detailed Description

A randomized clinical trial of TM treatment has been designed on patients with TMD of myofascial origin susceptible to dental treatment, complying with the ethical principles for biomedical research in humans formalized in the Declaration of Helsinki. The study has been approved by the Research Ethics Committee of the University of Jaén.

SUBJECTS Subjects are duly informed and their acceptance to participate is formalized by signing an informed consent document where they are also asked for permission to use their photos for the study. Participants are recruited from the Nogales Orthodontic Clinic in Úbeda, the Javier Ruiz Sequera Dental Clinic in Torreperogil, and the SM Medicodental Clinic in Úbeda, Spain. Subjects of legal age affected by myofascial TMD are included, with the diagnosis made using the Diagnostic Criteria for Temporomandibular Disorder (DMD). On the other hand, patients who are not in good physical condition are excluded. The participants were not qualified to understand or carry out the study. The selected participants were randomised into two groups using the Epidat 3.1 software (Conselleria de Sanidade, Xunta de Galicia, Spain), and assigned to a treatment group with physiotherapy plus a splint or another with a conventional approach prescribed with a splint by their dentists.

CALCULATION OF SAMPLE SIZE The sample size was calculated using the G*Power software (latest version 3.1.9.7; Heinrich-Heine University of Düsseldorf, Düsseldorf, Germany) based on the data provided by De Resende et al. A two-tailed hypothesis was considered, 95% power, a p value of 0.05 and an effect size on the VAS of 0.27. A correlation between repeated measures of 0.5 and an effect size of 0.25 were also considered. Taking into account three assessments of the study variables and two study groups, the present study should include a total sample size of at least 38 patients, 19 per group.

MEASUREMENTS All measurements are performed by a trained physiotherapist, who will not know which group each patient belongs to.

The sociodemographic variables taken are age, sex, height, BMI, educational level, whether they work, smoking habits, alcohol habits and physical activity.

Tests and questionnaires:

As for TMD, it is assessed using the DC/TMD, the 'gold standard' test for the diagnosis of TMD, although it is also assessed with the Fonseca Anamnestic Index: a questionnaire made up of 10 questions that can be answered as yes, no and sometimes with a score range between 0 and 100 points.

In addition, pain perception is assessed using the Numerical Pain Rating Scale, a test that grades pain between 0 and 10. In this study, the researchers used this test to assess TMD and neck pain.

To assess neck function, the researchers used the Neck Disability Index, a 10-item questionnaire that provides information on how neck pain has affected the ability to manage daily life.

INTERVENTION The treatment protocol for the physiotherapy plus splint group consists of 4 sessions of 20 minutes each of manual therapy that includes the manual techniques found in the previous systematic review: TMJ articulation, intraoral therapy for the pteregoid muscles, manual therapy for the masseter and temporal muscles, treatment of trigger points with ischemic pressure, and manual therapy for the muscles of the cervical region, sternocleidomastoid, suboccipital, and trapezius.

The treatment protocol for the control group consists of only the use of the splint as prescribed by the dentist. The assessments of the subjects in the physiotherapy plus splint group are carried out before and after each treatment, which will be repeated one week, one week after the latter, and one week after this. The assessments of the subjects in the control group will be carried out before placing the splint and one month after it.

DATA ANALYSIS Statistical analysis will be performed with a confidence level of 95% (p<0.05) and the statistical packages SPSS 19.0 and MedCalc 14.12.043 will be used. Continuous variables will be described by means and standard deviations and categorical variables with frequencies and percentages. The Kolmogorov-Smirnov test will be used to observe the normality of the distribution of the groups. The relationships between the variables will be analyzed by regression and Pearson correlation. Cohen's d will be calculated to measure the effect size in the bivariate analysis and will be calculated as the difference in measurements between the groups divided by the pooled standard deviation of both groups. Cohen's d can be interpreted as the effect size; if the result is 0.2 or less the effect is insignificant, between 0.2 and 0.5 the effect size is small, between 0.5 and 0.8 the effect is medium and a value greater than 0.8 the effect is large. For comparison of the two groups of patients, the Student t-test and the Chi-square test will be used.

Comparisons between the physiotherapy plus splint treatment group and the splint treatment group will be made using a repeated measures analysis of variance (ANOVA), followed by Bonferroni to compare the replicate means for the time points investigated.

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Úbeda, Spain, 23400
        • Clinica Villa Aragón

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Participants diagnosed with myofascial temporomandibular disorders according to DC/TMD criteria.
  • Participants over 18 years old (local legal age).

Exclusion Criteria:

  • Participants unable to understand the questionnaires and assessments required for the study due to any condition.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Manual therapy and splint therapy
Intervention based on manual therapy techniques and splint therapy
Manual therapy techniques including massage, trigger point pressure, muscle stretching and joint mobilization.
Dental splint used for temotoromandibular disorders treatment
Active Comparator: Splint therapy alone
Intervention based on splint therapy
Dental splint used for temotoromandibular disorders treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self reported Temporomandibular Functionning
Time Frame: From the enrollment to end of treatment at one month
-Fonseca Anamnestic Index: self reported questionnaire about tamporomandibular symptoms.
From the enrollment to end of treatment at one month
Mouth opening
Time Frame: From enrollment to the end of treatment at one month
Maximum mouth opening in millimeters
From enrollment to the end of treatment at one month
Temporomandibular functioning
Time Frame: From enrollment to the end of treatment at one month
-Helkimo Clinical Dysfunction Index: temporomandibular symptoms index to be fulfilled by evaluator.
From enrollment to the end of treatment at one month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cervical function
Time Frame: From enrollment to the end of treatment at one month
Neck Disability Index, questionnaire measuring cervical functioning or disability
From enrollment to the end of treatment at one month
Pain in temporomandibular joint
Time Frame: From enrollment to the end of treatment at one month
Temporomandibular pain felt by the participant measured with numerical pain rating scale (scores from 0 (no pain) to 10 (higher pain))
From enrollment to the end of treatment at one month
Headache or Cephalea
Time Frame: From enrollment to the end of treatment at one month
Self-reported headache symptoms measured with Head Impact Test questionnaire
From enrollment to the end of treatment at one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 6, 2025

Primary Completion (Actual)

April 30, 2025

Study Completion (Actual)

April 30, 2025

Study Registration Dates

First Submitted

February 23, 2025

First Submitted That Met QC Criteria

February 27, 2025

First Posted (Actual)

March 5, 2025

Study Record Updates

Last Update Posted (Actual)

May 4, 2025

Last Update Submitted That Met QC Criteria

April 30, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The data of the study will be available under reasonable request to the corresponding author or published in the Repository of the university of Jaen (www.ruja.es)

IPD Sharing Time Frame

From the publication of the manuscript about the study report until with no end date.

IPD Sharing Access Criteria

Any request by email will be attended, as well as everybody could access to RUJA repository as it is public. For access, people will have to request by email or access to www.ruja.es

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Temporomandibular Disorders (TMD)

Clinical Trials on Manual Therapy

Subscribe